FDA updates labeling for GAVRETO FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for RIGEL PHARMS. Active ingredient: PRALSETINIB. Decision date: 12/22/2025 Full text
There are no comments here yet...